eFinder

eFinder

Home › Corporate social responsibility in pharmaceuticals › Article

Rare disease families find roadmap to drug development at bootcamps

Cnbc · · 978 words · By Ryan Anastasio
Corporate social responsibility in pharmaceuticals Patient-led medical innovation Rare disease advocacy
open_in_new Read the original article: https://www.cnbc.com/2026/05/07/rare-disease-families-research-drug-development-…

psychologyDetected Techniques

warning
Loaded Language 80% confidence
Using words with strong emotional connotations to influence an audience.
warning
Appeal to Pity 70% confidence
Evoking sympathy to win support rather than using logical arguments.

fact_checkFact-Check Results

15 claims extracted and verified against multiple sources including cross-references, web search, and Wikipedia.

info Single Source 5
schedule Pending 5
check_circle Corroborated 3
help Insufficient Evidence 2
info
“Developing a new drug can cost a billion dollars and take more than a decade.”
SINGLE SOURCE
The provided web search results discuss generic drugs, drug prices, and weight-loss drugs, but none of the results provide specific data on the cost or duration of developing a new drug to corroborate the 'billion dollars' or 'decade' claim.
travel_explore
web search NEUTRAL — A generic drug must contain the same active ingredients as the original brand-name formulation. The U.S. Food and Drug Administration (FDA) requires generics to be identical to or within an acceptable…
https://en.wikipedia.org/wiki/Generic_drug
travel_explore
web search NEUTRAL — “Cost-related nonadherence is a significant and growing issue that is direct result of runaway drug prices and a failure to implement policies and regulations that make drugs more affordable.” The pri…
https://westhealth.org/news/new-study-predicts-more-than-1-1…
travel_explore
web search NEUTRAL — Originally developed to treat diabetes, these drugs are now being hailed as game changers for weight loss, offering results that few previous treatments could match.
https://www.bbc.com/news/articles/cx2g4411en3o
check_circle
“95% of the more than 10,000 rare diseases that exist do not have an FDA-approved treatment.”
CORROBORATED
Two independent sources confirm the statistic: one source explicitly states '95% of 10,000+ known #RareDiseases lacking FDA-approved treatments' and another cites NCATS.NIH.gov (2023) stating only 5% of 7,000+ known rare diseases have an FDA-approved treatment.
travel_explore
web search NEUTRAL — With 95% of 10,000+ known #RareDiseases lacking FDA-approved treatments, these milestones are victories for our entire #rare community. Graphic featuring NORD logo and headline, "Celebrating Breakthro…
https://www.linkedin.com/posts/national-organization-for-rar…
travel_explore
web search NEUTRAL — Of the approximately 280 new orphan drugs approved by the FDA between 2003 and 2022, nearly one-quarter were approved for at least one follow-on use for another rare disease. In the oncology space alo…
https://friendsofcancerresearch.org/news/rare-disease-patien…
travel_explore
web search NEUTRAL — Of the 7,000+ known rare diseases, only 5% have an FDA-approved treatment (NCATS.NIH.gov, 2023).The Treatment Gap: Why So Few Rare Diseases Have Therapies. The lack of treatment options is one of the …
https://slc6a1connect.org/2025/02/27/understanding-rare-dise…
info
“Rare As One — a project funded by the Chan Zuckerberg Biohub... released a report that showed of the 20 organizations it funded when the program launched in 2019, half of them were involved in clinical trials within five years.”
SINGLE SOURCE
While the evidence confirms the existence of the Chan Zuckerberg Biohub and its funding of science, there is no mention of a 'Rare As One' project or a report stating that 50% of 20 funded organizations entered clinical trials within five years.
travel_explore
web search NEUTRAL — Chan and Zuckerberg have pledged 99% of their lifetime wealth — from shares of Meta Platforms, where Zuckerberg is CEO — toward these efforts. Since 2016, when Biohub launched, they have donated $4 bi…
https://www.clickorlando.com/business/2025/11/06/zuckerberg-…
travel_explore
web search NEUTRAL — This funding opportunity supports scaling the Chan Zuckerberg Biohub model to pursue the toughest and most important scientific challenges by bringing together leading U.S.-based scientific and techno…
https://chanzuckerberg.com/science/science-funding/
travel_explore
web search NEUTRAL — The organisation said the data it generates will be made open and freely available to researchers worldwide. Biohub says AI simulations of human cells could allow researchers to study disease digitall…
https://www.euronews.com/next/2026/05/04/what-is-mark-zucker…
check_circle
“Ultragenyx... Twice a year the company hosts Rare Bootcamp, a multi-day forum that helps families learn about conducting rare disease research and the important steps that go into developing a new drug.”
CORROBORATED
Multiple sources confirm that Ultragenyx hosts 'Rare Bootcamp,' a multi-day forum designed to help parents and patient advocates learn about rare disease research and drug development.
travel_explore
web search NEUTRAL — The Rare Bootcamp is a multi-day forum hosted by Ultragenyx and EveryLife Foundation for Rare Diseases to provide parents and other patient advocates seeking to develop rare disease therapies with an …
https://www.rarebootcamp.com/
travel_explore
web search NEUTRAL — Rare Bootcamp, a multi-day forum sponsored by Ultragenyx that the family heard about through word of mouth, was started in 2017 to support and empower families as they step into their role as advocate…
https://www.massbio.org/news/recent-news/rare-disease-parent…
travel_explore
web search NEUTRAL — Each Rare Bootcamp is a reminder of what’s at stake for rare disease families and shows the power of collaboration in pushing the boundaries of what’s possible.
https://www.linkedin.com/posts/ultragenyx_each-rare-bootcamp…
info
“The event is free for attendees, and is sponsored by other biotech firms, such as Alexion, BioMarin, GeneDx and BridgeBio”
SINGLE SOURCE
The evidence confirms the existence and purpose of the Rare Bootcamp, but the specific list of sponsors (Alexion, BioMarin, GeneDx, BridgeBio) and the fact that it is free are not explicitly detailed in the provided search snippets.
travel_explore
web search NEUTRAL — The Rare Bootcamp is designed to provide parents and patient advocates seeking to develop rare disease therapies with an opportunity to learn from rare disease drug development experts and to connect …
https://www.rarebootcamp.com/
travel_explore
web search NEUTRAL — Each Rare Bootcamp is a reminder of what’s at stake for rare disease families and shows the power of collaboration in pushing the boundaries of what’s possible.
https://www.linkedin.com/posts/ultragenyx_each-rare-bootcamp…
travel_explore
web search NEUTRAL — Introducing RARE Entrepreneur Bootcamp. The event for parents developing rare disease drugs for their children. Jeff Blake - Senior Director, Corporate Communications at Ultragenyx.
https://www.ultragenyx.de/rare-entrepreneur-bootcamp/
info
“During its most recent bootcamp in Boston last month, the company held more than 20 sessions covering the full spectrum of drug development”
SINGLE SOURCE
The evidence confirms the bootcamp exists and is hosted by Ultragenyx, but there is no specific mention of a 'most recent bootcamp in Boston last month' or the number of sessions (20+) held.
travel_explore
web search NEUTRAL — ABOUT US Rare Bootcamp The Rare Bootcamp is a multi-day forum hosted by Ultragenyx and EveryLife Foundation for Rare Diseases to provide parents and other patient advocates seeking to develop rare dis…
https://www.rarebootcamp.com/
travel_explore
web search NEUTRAL — Each Rare Bootcamp session, we're reminded of the resilience and determination of the rare disease community. Thank you to our co-host, EveryLife Foundation for Rare Diseases and our sponsors.
https://www.linkedin.com/posts/ultragenyx_each-rare-bootcamp…
travel_explore
web search NEUTRAL — The first Rare Bootcamp took place in 2017, and each year the event offers us the chance to connect with parents and patient advocates who inspire us and the other passionate presenters and sponsors. …
https://www.ultragenyx.com/video-this-bootcamp-helps-parents…
check_circle
“Ultragenyx founder and CEO Emil Kakkis launched the bootcamps nine years ago”
CORROBORATED
Multiple sources confirm that the bootcamp was launched by Ultragenyx CEO Dr. Emil Kakkis. One source specifically states it was started in 2017, which aligns with the 'nine years ago' claim (relative to a 2026 context or approximate timeline).
travel_explore
web search NEUTRAL — Ultragenyx Pharmaceutical Inc. is an American biopharmaceutical company involved in the research and development of novel products for treatment of rare and ultra-rare genetic diseases for which there…
https://en.wikipedia.org/wiki/Ultragenyx
travel_explore
web search NEUTRAL — The bootcamp was launched by Ultragenyx CEO Dr. Emil Kakkis, whose long-standing philosophy has been simple but powerful: when families ask for help, you help.
https://www.rarefutures.org/news/learning-how-to-build-a-pat…
travel_explore
web search NEUTRAL — Dr. Emil Kakkis, founder, president and CEO of Ultragenyx, understands these families’ frustration and desperation. When Kakkis, whose background is in academia, started out in the biotech sector he r…
https://www.pharmavoice.com/news/Ultragenyx-CEO-bootcamp-rar…
info
“hereditary spastic paraplegia type 26, a progressive neurodegenerative disorder”
SINGLE SOURCE
The search results returned information about the movie 'Hereditary' rather than the medical condition 'hereditary spastic paraplegia type 26'. No medical evidence was provided to verify the claim.
travel_explore
web search NEUTRAL — Hereditary premiered at the Sundance Film Festival on January 21, 2018, and was theatrically released in the United States on June 8. The film received critical acclaim, and was a commercial success, …
https://en.wikipedia.org/wiki/Hereditary_(film)
travel_explore
web search NEUTRAL — Jun 8, 2018 · Hereditary: Directed by Ari Aster. With Toni Collette, Milly Shapiro, Gabriel Byrne, Alex Wolff. A grieving family is haunted by tragic and disturbing occurrences.
https://www.imdb.com/title/tt7784604/
travel_explore
web search NEUTRAL — Toni Collette delivers a soul-shattering performance in Hereditary that reminds us how much sacrifice parenthood is and how deeply parents can scar their children, utterly beyond repair.
https://www.rottentomatoes.com/m/hereditary
help
“a gene therapy existed for a similar disorder called SPG 50.”
INSUFFICIENT EVIDENCE
No evidence was found after searching for gene therapy for SPG 50.
help
“a rare neurodevelopmental disorder called ReNU2.”
INSUFFICIENT EVIDENCE
No evidence was found after searching for a disorder called ReNU2.
schedule
“the gene was only identified in April 2025.”
PENDING
schedule
“about 60 families in 17 countries have identified that their child has the disorder [ReNU2].”
PENDING
schedule
“The bootcamp, which is co-hosted by the EveryLife Foundation — an advocacy group founded by Kakkis in 2009”
PENDING
schedule
“Roughly two dozen attendees attended last month's event, and since it launched about 235 people from 142 organizations have completed the program.”
PENDING
schedule
“the RARE Advocate Development Brain Workshop... is hosted by the Rare Epilepsy Network, Mahzi Therapeutics and the advocacy group Global Genes.”
PENDING
info Disclaimer: This analysis is generated by AI and should be used as a starting point for critical thinking, not as definitive truth. Claims are verified against publicly available sources. Always consult the original article and additional sources for complete context.